CRISPR/Cas9 Inducible Systems for Neurodegenerative Disease
Publication
, Conference
Asmus, N; Kantor, B
Published in: MOLECULAR THERAPY
2021
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2021
Volume
29
Issue
4
Start / End Page
415 / 415
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Asmus, N., & Kantor, B. (2021). CRISPR/Cas9 Inducible Systems for Neurodegenerative Disease. In MOLECULAR THERAPY (Vol. 29, pp. 415–415).
Asmus, Natalie, and Boris Kantor. “CRISPR/Cas9 Inducible Systems for Neurodegenerative Disease.” In MOLECULAR THERAPY, 29:415–415, 2021.
Asmus N, Kantor B. CRISPR/Cas9 Inducible Systems for Neurodegenerative Disease. In: MOLECULAR THERAPY. 2021. p. 415–415.
Asmus, Natalie, and Boris Kantor. “CRISPR/Cas9 Inducible Systems for Neurodegenerative Disease.” MOLECULAR THERAPY, vol. 29, no. 4, 2021, pp. 415–415.
Asmus N, Kantor B. CRISPR/Cas9 Inducible Systems for Neurodegenerative Disease. MOLECULAR THERAPY. 2021. p. 415–415.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2021
Volume
29
Issue
4
Start / End Page
415 / 415
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences